October 21, 2009 β King Pharmaceuticals Inc. said today the U.S. Food and Drug Administration issued a complete ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
October 19, 2009 β Boehringer Ingelheim Pharmaceuticals Inc. said today the FDA approved the supplemental new ...
October 19, 2009
October 16, 2009 β AstraZeneca yesterday said the U.S. Food and Drug Administration cleared CRESTOR (rosuvastatin ...
October 16, 2009
October 12, 2009 β Daiichi Sankyo Inc. (DSI) last week said the U.S. Food and Drug Administration (FDA) approved ...
October 12, 2009
October 9, 2009 β CardioPharma is beginning the final funding phase before submitting an FDA new drug application ...
October 09, 2009October 8, 2009 β In a recent survey of more than 2,000 U.S. physicians conducted by Epocrates Inc., cardiologists ...
October 08, 2009
October 6, 2009 β The Harvard Clinical Research Institute (HCRI) said last week the first patients are enrolled ...
October 06, 2009October 5, 2009 β A reduction in stroke was observed in patients with atrial fibrillation (AF) who received ...
October 05, 2009October 5, 2009 β A new analysis reaffirms that Lexiscan (regadenoson) Injection, the first selective A2A ...
October 05, 2009September 28, 2009 β New data from the phase III PLATO study showed that ticagrelor (BRILINTA) provided 16 ...
September 29, 2009September 28, 2009 β Sanofi-aventis announced last week the Committee for Medicinal Products for Human Use (CHMP) ...
September 29, 2009
September 18, 2009 β Patientsβ response to anti-platelet therapy after percutaneous coronary intervention (PCI) ...
September 18, 2009
September 18, 2009 β The FDA has approved Valturna (aliskiren and valsartan) tablets, the first and only medicine ...
September 18, 2009September 17, 2009 β The 13th Annual Scientific Meeting of the Heart Failure Society of America (HFSA) on ...
September 17, 2009
Feature | Dave Fornell
In August Daiichi Sankyo and Eli Lilly and Company launched U.S. sales of Effient (prasugrel), a new antiplatelet ...
September 17, 2009Β© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now